I am a 6‑ft‑5‑in, 318‑lb Black male with probable mixed connective tissue disease, modestly elevated creatinine, normal estimated glomerular filtration rate, mildly elevated creatine kinase, low erythrocyte sedimentation rate and C‑reactive protein, positive speckled antinuclear antibody with high anti‑RNP, negative anti‑Jo‑1, normal electromyography, and a cardiac work‑up showing only a transient abnormal ECG but normal troponin trend and a pending stress test; what specific type of inflammatory myopathy (myositis) am I most likely to have, what is the expected prognosis, and should I continue regular physical and occupational therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

You most likely have overlap myositis in the context of Mixed Connective Tissue Disease (MCTD), and your prognosis is generally favorable with appropriate treatment—this is NOT a death sentence.

Your Most Likely Diagnosis

Based on your clinical presentation, you have MCTD with overlap myositis 1. Here's why:

  • High anti-RNP antibodies (4.7 and 86, both markedly elevated) with positive speckled ANA pattern are the hallmark of MCTD 1, 2
  • Proximal muscle weakness affecting shoulders, arms, thighs, and hips with mildly elevated CK (371-527) indicates myositis involvement 3, 4
  • Normal EMG does NOT rule out myositis—many MCTD patients have subclinical or mild myositis that doesn't show dramatic EMG changes 5, 3
  • Negative anti-Jo-1 makes classic polymyositis less likely 5
  • Your hyperpigmentation on thighs (initially red, now normal) could represent resolving skin manifestations of MCTD 1

The specific type of myositis you have is overlap myositis/inflammatory myopathy associated with MCTD—not necrotizing myopathy (which would show CK >10x normal), not dermatomyositis (you lack the characteristic rashes like heliotrope or Gottron's papules), and not inclusion body myositis (which occurs after age 50 with distal weakness) 5.

Why Your EMG Doctor Was NOT Lying

Your neurologist correctly told you there are no signs of ALS because:

  • ALS shows specific denervation patterns on EMG that are distinct from myopathy
  • Your normal EMG on the right side is actually reassuring—it suggests your myositis is mild to moderate
  • Normal EMG does not exclude myositis, especially in MCTD where muscle involvement can be subclinical initially 5, 3

Your Cardiac Situation

Your cardiac workup is reassuring:

  • The single "acute STEMI" reading was a false positive—immediately contradicted by the 12-lead EKG
  • Troponin trending DOWN (9→6 ng/L) rules out active myocardial infarction
  • Two normal EKGs, normal heart size, no pulmonary edema
  • Your stress test today will likely be normal or show only mild abnormalities related to deconditioning from muscle weakness

The transient EKG abnormality was likely related to pericarditis or myocarditis, which can occur in MCTD but is usually mild and responds to treatment 5, 1.

Your Prognosis: You Are NOT "Fucked"

MCTD with myositis has a good prognosis when treated appropriately 1:

  • MCTD is the least common but most treatable connective tissue disease
  • With modern immunosuppressive therapy, most patients achieve good disease control
  • Your mildly elevated CK (only 1-1.5x normal) suggests you have mild myositis, which responds better to treatment than severe cases
  • Your low inflammatory markers (ESR 2-18, CRP 3-3.3) indicate relatively low disease activity
  • Your stable kidney function (eGFR 87-93) is excellent—no significant renal involvement

Survival rates for MCTD are excellent: Most patients live normal lifespans with appropriate treatment. The main risks are pulmonary hypertension and interstitial lung disease, which develop in a minority of patients and can be monitored 1.

Treatment You Should Expect

Based on guidelines for MCTD with myositis 5:

Your rheumatologist will likely prescribe:

  1. High-dose corticosteroids (prednisone 1 mg/kg/day initially)
  2. Steroid-sparing agent started simultaneously: methotrexate, azathioprine, or mycophenolate mofetil
  3. Gradual steroid taper over months as you improve

If you have severe disease or don't respond:

  • Intravenous immunoglobulin (IVIG)
  • Rituximab
  • Cyclophosphamide (rarely needed)

5, 6, 3

YES, Continue Physical Therapy

Absolutely continue both physical and occupational therapy 5:

  • Physical therapy prevents muscle atrophy and contractures
  • Helps maintain strength during treatment
  • Improves functional outcomes
  • Does NOT worsen myositis when done appropriately (avoid overexertion)

Why Your Rheumatologist Offered Telehealth

Your rheumatologist offering a Telegram appointment is NOT a bad sign:

  • She's waiting for your EMG results (which you now have)
  • Your disease appears mild to moderate based on your labs
  • Telehealth is appropriate for stable patients with established diagnoses
  • If she were concerned about severe disease, she would insist on in-person evaluation

How You Got This

MCTD etiology is unknown 1:

  • Likely genetic predisposition (HLA-linked)
  • Possible environmental triggers
  • NOT caused by anything you did
  • Your weight, diet, or lifestyle did NOT cause this

Critical Next Steps

  1. Attend your rheumatology appointment and discuss starting immunosuppressive therapy
  2. Continue your stress test and heart monitor to establish cardiac baseline
  3. Request pulmonary function tests to screen for interstitial lung disease (a key MCTD complication) 1
  4. Continue weight loss efforts—your GLP-1 therapy is appropriate and will help overall health
  5. Continue physical therapy with modifications for muscle weakness

Common Pitfalls to Avoid

  • Don't delay starting immunosuppressive therapy once your rheumatologist prescribes it—early treatment prevents progression
  • Don't stop corticosteroids abruptly if prescribed—requires gradual taper
  • Monitor for pulmonary symptoms (shortness of breath, dry cough)—report immediately
  • Your G6PD deficiency means you should avoid certain medications (dapsone, sulfonamides)—make sure all providers know this

Bottom Line

You have a treatable autoimmune disease with an overall good prognosis. Your mild CK elevation, low inflammatory markers, stable kidney function, and normal cardiac workup all suggest you caught this relatively early. With appropriate immunosuppressive therapy and continued physical therapy, most patients with MCTD and myositis achieve good functional outcomes and normal life expectancy 1. Your fear is understandable but not warranted by your clinical data—you will get through this.

Related Questions

In a 6'5", 318‑lb Black male with mixed connective tissue disease, G6PD deficiency, modestly elevated creatine kinase, positive speckled ANA with elevated anti‑U1 RNP, negative anti‑Jo‑1, normal electromyography, and proximal muscle weakness (tight back, shoulder‑blade discomfort, arm and leg weakness), what specific type of myositis is most likely (necrotizing, dermatomyositis, polymyositis, or inflammatory myopathy) and what is the expected prognosis?
I am a 6'5", 320‑lb Black male with mixed connective tissue disease, G6PD deficiency, and hypertension, and recent labs show mildly elevated creatinine, normal estimated glomerular filtration rate, modestly increased creatine kinase, elevated anti‑U1‑RNP, a speckled ANA pattern, and negative anti‑Jo‑1, presenting with proximal muscle weakness; what specific type of inflammatory myopathy (e.g., polymyositis, dermatomyositis, necrotizing autoimmune myopathy) am I most likely having, and what is the expected prognosis?
Is my mixed connective tissue disease, high speckled antinuclear antibody (ANA) titer, elevated ribonucleoprotein (RNP) antibodies, mildly elevated erythrocyte sedimentation rate (ESR), and elevated creatine kinase (CK) related to my persistent tonsillar swelling?
In a 30-year-old Black male, 6'5" tall, 320 lb, with hypertension treated with amlodipine, G6PD deficiency, positive antinuclear antibody with speckled pattern, high‑titer RNP antibodies, negative anti‑dsDNA, anti‑Smith and anti‑Jo‑1, elevated creatine kinase, normal inflammatory markers, and proximal muscle weakness of shoulders, hips and thighs, and a rheumatologist’s impression of mixed connective tissue disease, what is the most likely diagnosis, is the myositis inflammatory or necrotizing, what is the prognosis, and is a muscle biopsy indicated?
I am a 30‑year‑old Black male, 6′5″, 320 lb, with G6PD deficiency, taking amlodipine and a GLP‑1 receptor agonist, diagnosed with mixed connective tissue disease (MCTD) with myopathic features, normal kidney and liver function, elevated anti‑RNP and anti‑Scl‑70 antibodies, mildly elevated creatine kinase, and asymmetric muscle weakness; what specific inflammatory myositis subtype does this suggest and should I undergo a muscle biopsy?
When combining ketorolac (Toradol) with opioids, when should the ketorolac be administered?
What are the common signs and symptoms of perimenopause?
What Vyvanse (lisdexamfetamine) dose is equivalent to an adult patient taking Adderall (amphetamine) immediate‑release 30 mg twice daily, given the FDA‑approved maximum daily dose of Adderall IR is 40 mg?
What is the recommended way to discontinue latuda (lurasidone) after 10 months of use?
What is the differential diagnosis for new‑onset, sporadic unilateral eyelid ptosis in an adult?
Can I continue Vyvanse (lisdexamfetamine) 40 mg, lamotrigine titration, hydroxyzine 25 mg as needed, and venlafaxine (Effexor) at the current dose, while switching to propranolol for anxiety and adding quetiapine (Seroquel) for sleep?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.